Answers are grounded in this paper and cite their sources.
The presence of cell-surface antigens on line10 hepatocarcinoma cells was demonstrated by immunoelectronmicroscopy (IEM) with the use of xenogeneic and syngeneic tumor-specific antibody and syngeneic BCG-induced antibody. This confirmed that in addition to tumor-specific antigen(s) there are common antigens between line-10 hepatocarcinoma cells and BCG organisms. The specificity of this cross-reactivity was further supported by blocking experiments and absorption of the specific antibody to BCG organisms, with subsequent IEM of the BCG and loss of reactivity to tumor cells. Complement- dependent serum cytotoxicity was correlated with the IEM assay. Cross-reactivity of the BCG-specific antibody with the surface of cells of a human melanoma culture grown from an excised subcutaneous melanoma was also demonstrated by IEM.
No takes yet. Share an insight, caveat, or question.
Bucana et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: